All changes for the tissue Anatomical System (4331)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1042
Overweight/Obesity - Obese (Male)
Pathological
whole body
Human
—
SeriesIncidence
DAA1041
Overweight/Obesity - Overweight (Female)
Pathological
whole body
Human
—
SeriesIncidence
DAA1040
Overweight/Obesity - Overweight (Male)
Pathological
whole body
Human
—
SeriesIncidence
DAA1045
Overweight/Obesity - Severely Obese (Female)
Pathological
whole body
Human
—
SeriesIncidence
DAA1044
Overweight/Obesity - Severely Obese (Male)
Pathological
whole body
Human
—
SeriesIncidence
DAA701
Oxidative increase in cystine/cysteine ratio
Physiological
plasma
Human
—
—
DAA163
oxysterol binding protein
Molecular
brain
Human
OSBP
8.0% Decrease Gene Expression Level
DAA1280
oxytocin receptor
Molecular
cochlea
Mouse
Oxtr
19.0% Increase Gene Expression Level
DAA1977
p16 expression increases
Molecular
whole body
Mouse
Cdkn2a
—
DAA165
p21 protein (Cdc42/Rac)-activated kinase 1
Molecular
brain
Human
PAK1
23.0% Decrease Gene Expression Level
DAA524
paired immunoglobin-like type 2 receptor beta
Molecular
skeletal muscle
Human
PILRB
6.0% Increase Gene Expression Level
DAA1312
paired-like homeodomain transcription factor 2
Molecular
hematological system
Mouse
Pitx2
17.0% Decrease Gene Expression Level
DAA1971
Pancreatic Beta-cell replication decrease
Physiological
pancreas
Mouse
—
—
DAA595
Pancreatic cancer
Pathological
pancreas
Human
—
SeriesMorbidity
DAA1803
pannexin 1
Molecular
muscle
Mouse
Panx1
28.0% Increase Gene Expression Level
DAA2247
pannexin 1 decreases with age
Molecular
frontal lobe
Human
PANX1
59.9% Decrease Gene Expression Level
DAA2268
pannexin 1 decreases with age
Molecular
temporal lobe
Human
PANX1
41.6% Decrease Gene Expression Level
DAA2258
pannexin 1 decreases with age
Molecular
parietal lobe
Human
PANX1
50.0% Decrease Gene Expression Level
DAA2351
Pannexin 2 decreases with age
Molecular
frontal lobe
Human
PANX2
8.1% Decrease Gene Expression Level
DAA2353
Pannexin 2 decreases with age
Molecular
temporal lobe
Human
PANX2
16.5% Decrease Gene Expression Level
DAA2352
Pannexin 2 decreases with age
Molecular
hippocampus
Human
PANX2
19.1% Decrease Gene Expression Level
DAA1804
par-6 (partitioning defective 6,) homolog alpha (C. elegans)
Molecular
muscle
Mouse
Pard6a
3.0% Decrease Gene Expression Level
DAA1506
paraoxonase 2
Molecular
kidney
Mouse
Pon2
8.0% Decrease Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA449
paraspeckle component 1
Molecular
skeletal muscle
Human
PSPC1
2.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1042 | Overweight/Obesity - Obese (Male) | Pathological | whole body | Human | — | SeriesIncidence | |
DAA1041 | Overweight/Obesity - Overweight (Female) | Pathological | whole body | Human | — | SeriesIncidence | |
DAA1040 | Overweight/Obesity - Overweight (Male) | Pathological | whole body | Human | — | SeriesIncidence | |
DAA1045 | Overweight/Obesity - Severely Obese (Female) | Pathological | whole body | Human | — | SeriesIncidence | |
DAA1044 | Overweight/Obesity - Severely Obese (Male) | Pathological | whole body | Human | — | SeriesIncidence | |
DAA701 | Oxidative increase in cystine/cysteine ratio | Physiological | plasma | Human | — | — | |
DAA163 | oxysterol binding protein | Molecular | brain | Human | OSBP | 8.0% Decrease Gene Expression Level | |
DAA1280 | oxytocin receptor | Molecular | cochlea | Mouse | Oxtr | 19.0% Increase Gene Expression Level | |
DAA1977 | p16 expression increases | Molecular | whole body | Mouse | Cdkn2a | — | |
DAA165 | p21 protein (Cdc42/Rac)-activated kinase 1 | Molecular | brain | Human | PAK1 | 23.0% Decrease Gene Expression Level | |
DAA524 | paired immunoglobin-like type 2 receptor beta | Molecular | skeletal muscle | Human | PILRB | 6.0% Increase Gene Expression Level | |
DAA1312 | paired-like homeodomain transcription factor 2 | Molecular | hematological system | Mouse | Pitx2 | 17.0% Decrease Gene Expression Level | |
DAA1971 | Pancreatic Beta-cell replication decrease | Physiological | pancreas | Mouse | — | — | |
DAA595 | Pancreatic cancer | Pathological | pancreas | Human | — | SeriesMorbidity | |
DAA1803 | pannexin 1 | Molecular | muscle | Mouse | Panx1 | 28.0% Increase Gene Expression Level | |
DAA2247 | pannexin 1 decreases with age | Molecular | frontal lobe | Human | PANX1 | 59.9% Decrease Gene Expression Level | |
DAA2268 | pannexin 1 decreases with age | Molecular | temporal lobe | Human | PANX1 | 41.6% Decrease Gene Expression Level | |
DAA2258 | pannexin 1 decreases with age | Molecular | parietal lobe | Human | PANX1 | 50.0% Decrease Gene Expression Level | |
DAA2351 | Pannexin 2 decreases with age | Molecular | frontal lobe | Human | PANX2 | 8.1% Decrease Gene Expression Level | |
DAA2353 | Pannexin 2 decreases with age | Molecular | temporal lobe | Human | PANX2 | 16.5% Decrease Gene Expression Level | |
DAA2352 | Pannexin 2 decreases with age | Molecular | hippocampus | Human | PANX2 | 19.1% Decrease Gene Expression Level | |
DAA1804 | par-6 (partitioning defective 6,) homolog alpha (C. elegans) | Molecular | muscle | Mouse | Pard6a | 3.0% Decrease Gene Expression Level | |
DAA1506 | paraoxonase 2 | Molecular | kidney | Mouse | Pon2 | 8.0% Decrease Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA449 | paraspeckle component 1 | Molecular | skeletal muscle | Human | PSPC1 | 2.0% Increase Gene Expression Level |